CRISPR Therapeutics (CRSP) P/E (2016 - 2026)
CRISPR Therapeutics (CRSP) P/E from Oct 19, 2016 to Jul 21, 2026. The TTM CRISPR Therapeutics (CRSP) P/E is -7.85. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of CRISPR Therapeutics (CRSP)
| Year | P/E | Change |
|---|---|---|
| 2026 | -7.85 | -3.70% |
| 2025 | -8.15 | -10.85% |
| 2024 | -9.15 | -34.65% |
| 2023 | -14.00 | +201.97% |
| 2022 | -4.64 | -130.51% |
| 2021 | 15.19 | -151.36% |
| 2020 | -29.58 | -152.80% |
| 2019 | 56.03 | -751.66% |
| 2018 | -8.60 | -42.54% |
| 2017 | -14.96 | +64.05% |
| 2016 | -9.12 | N/A |
Comparison CRISPR Therapeutics (CRSP) P/E with competitors
CRISPR Therapeutics (CRSP) P/E is -7.85.